Company intelligence / Profile preview

Sterix

Slough / London area, England, United Kingdomsteris.com ↗

Ownership: Private
Development stage: Commercial

Overview

Sterix focused on the design and discovery of novel steroid derivatives and small molecule drugs that modulate steroid hormone action for the treatment of hormone-dependent cancers. The company advanced several programs into preclinical and early clinical development before being acquired.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Partnerships

IpsenUniversity of BathImperial College London

Beyond the preview

Go deeper on Sterix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sterix.

Explore the full profile